Log in

MVP Medical Developments International Limited ASX · Australia

Medical Developments International (MVP) news

Medical Developments International Limited is a public biotech or pharmaceutical company listed on ASX under the ticker MVP, recorded under Australia. The directory classifies it as Pharmaceuticals: Major. aibio.space tracks 2,820 public biotech companies worldwide and publishes investor news on them.

Latest Medical Developments International news

We have not published a story on Medical Developments International yet. When there is news, it will appear here.

Questions about Medical Developments International

What is the ticker symbol of Medical Developments International?

Medical Developments International Limited trades under the ticker MVP on ASX.

Where is Medical Developments International listed?

Medical Developments International Limited is listed on ASX. Our directory also records these other listings: OTC:MDDVF.

Which country or territory is Medical Developments International listed under?

Our directory records Medical Developments International Limited under Australia.

What does Medical Developments International do?

Our directory classifies Medical Developments International Limited as: Pharmaceuticals: Major. This is a directory classification, not a description of the pipeline.

What is the ISIN of Medical Developments International?

The ISIN recorded for Medical Developments International Limited is AU000000MVP2.

Does aibio.space cover Medical Developments International?

aibio.space lists Medical Developments International Limited among 2,820 public biotech companies and publishes its news here as stories appear.

Which companies are similar to Medical Developments International?

Companies in our directory listed in the same country and business area as Medical Developments International: IDT Australia, Syntara, Epsilon Healthcare, Percheron Therapeutics, Vectus Biosystems, Mayne Pharma Group.

Investor discussion: Medical Developments International

Members talk about Medical Developments International (MVP). Reader posts, not aibio.space reporting, and not investment advice.

Rules
  1. Securities violations are strictly forbidden. No market manipulation, no pump-and-dump, no false or misleading statements, and no inside information.
  2. Say whether you hold the stock. Every post states long, short or no position.
  3. No paid or sponsored posts. Do not post for anyone who pays or rewards you.
  4. No buy or sell calls and no price targets.
  5. No accusations of crime or fraud against named people unless you link a court filing or a regulator's release that makes them.
  6. No personal details and no spam. No links at all for your first 7 days as a member.

Posts that break the rules may be deleted without notice, and the account restricted or closed. See the terms and the privacy policy.

Stock chart

Price chart and quote supplied by TradingView, delayed as the exchange requires. It loads only if you choose to show it. Information only, not investment advice. Open ASX:MVP on TradingView.

Listing details

Medical Developments International Limited is a public biotech or pharmaceutical company listed on ASX under the ticker MVP, recorded under Australia. The directory classifies it as Pharmaceuticals: Major. aibio.space tracks 2,820 public biotech companies worldwide and publishes investor news on them.

Company
Medical Developments International Limited
Ticker
MVP
Listing
ASX
Country or territory
Australia
Business scope
Pharmaceuticals: Major
ISIN
AU000000MVP2
Other listed symbols
OTC:MDDVF
Last quote in directory
2026-10-22
Directory source
Listing page

Listing facts come from our company directory, researched on October 22, 2026. A listing record does not certify that a security currently trades. Tell us about a change. Work at this company? Claim this page.

Published and maintained by aibio.space. Not investment advice. How we work.

Who manages this page This page is managed by aibio.space. The company does not run, edit or pay for this page. News, desk views and Investor Ranks are written and managed independently by aibio.space under our editorial and analytical judgment. Opinion only, not investment advice. How we work · Terms · Request a correction

Full desks

Every other company has a starter desk. Search above to open one.

Settings

Appearance
Text size
Motion

Stops the news strip and the share rollers.

Your choices are saved in this browser only.

Free membership

Read aibio.space in full, free

Subscribe with your email address to read every story, company desk and profile in full. It costs nothing. In return, you agree that we may email you, including offers. One click to unsubscribe.

No card, no password. With email, we send one message to confirm your address first. With Google or Facebook we receive only your email address. Not investment advice.